Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
University of Oklahoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
University of Nebraska
National Institutes of Health Clinical Center (CC)
Jonsson Comprehensive Cancer Center
Astellas Pharma Inc
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Nagoya University
Instituto do Cancer do Estado de São Paulo
University of Chicago
Astellas Pharma Inc
Eli Lilly and Company
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Hoosier Cancer Research Network
Eli Lilly and Company
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
pharmaand GmbH
Mayo Clinic
Wake Forest University Health Sciences
University of California, Davis
Imperial College London
UNICANCER
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
National Cancer Institute (NCI)
Karolinska University Hospital
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
Cardiff University
Karolinska University Hospital
Cardiff University
Wake Forest University Health Sciences
Cardiff University